The pharmaceutical industry has called for a careful and phased implementation of Trade Margin Rationalisation (TMR), urging the government to ensure that the Drug Price Control Order (DPCO) is equipped to meet future challenges while fostering industry growth. Leading industry associations have put forward a series of recommendations to make TMR more effective, balanced, and supportive of all stakeholders in the pharmaceutical supply chain.
However, the industry is cautious about expanding TMR across the pharmaceutical sector, recognising the complexities involved. Industry associations have noted that while TMR is a promising tool for ensuring fair pricing, it must be applied in a manner that avoids unintended consequences such as supply chain disruptions, reduced market access, or the undermining of small and medium-sized enterprises (MSMEs).
Recognising the importance of a robust and future-ready DPCO, industry leaders have outlined key recommendations for how TMR should be implemented to achieve the desired balance between affordability and industry growth. These recommendations focus on maintaining a healthy supply chain while protecting the interests of consumers and MSMEs alike.
Industry stakeholders have called for TMR to be implemented in phases, with a focus on high-value, non-scheduled formulations as a starting point. The roll-out should be prospective, applying only to batches manufactured after the notification is issued, and stakeholders should be informed of TMR guidelines 3 to 6 months in advance. This phased approach would allow companies to adjust to the new regulations without major disruptions.
Bu hikaye Bio Spectrum dergisinin BioSpectrum India Oct 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Bio Spectrum dergisinin BioSpectrum India Oct 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Can phased trade margin rationalisation boost pharma growth?
The pharma representatives of the Laghu Udyog Bharati (LUB), an RSS affiliate and a not-forprofit Pan India Organisation with the aim of empowering Micro and Small enterprises in the country since its formation in 1994, on July 24, had a meeting with officials from the Department of Pharmaceuticals, and discussed key issues such as Trade Margin Rationalisation (TMR), Schedule-M extension, Revised PTUS Hurdles, and the Drug Tribunal Board formation. LUB Pharma proposed the innovative \"One Nation-One Molecule-One MRP\" and advocated for the top 100 companies to sell their generic brands at molecule name and affordable Maximum Retail Price (MRP) for patient benefits. Here we are looking at a series of recommendations from industry associations to make TMR more effective, balanced, and supportive of all stakeholders in the pharmaceutical supply chain.
Why industry-academia collaboration is crucial for biomedical sciences
India's growing biomedical sciences sector is ripe with potential, yet it faces several challenges. In recent years, there has been a notable shift in government policies, private investments, and educational reforms aimed at boosting research and innovation in this critical area. One of the key factors that can significantly influence this growth is the collaboration between industry and academia. Such partnerships have the power to not only fuel the biomedical sector but also strengthen India's position as a global player in healthcare research and innovation.
Study reveals role of Ayurvedic Whole System in management of Rheumatoid Arthritis
A new scientific study has revealed the significant effectiveness of the Ayurvedic Whole System (AWS) in the management of Rheumatoid Arthritis (RA), a chronic autoimmune disorder affecting millions worldwide.
Amit Mookim steps in as CEO of Immuneel Therapeutics
Bengaluru-based Immuneel Therapeutics, a pioneering cell and gene therapy platform, has announced the appointment of Amit Mookim as its new Chief Executive Officer (CEO).
Meril expands healthcare education network with opening of Satellite Academy in Kochi
Meril, a global medical technology and education leader, has expanded its healthcare education network by launching the Meril Satellite Academy in Kerala’s port city, Kochi.
Skye Air Mobility partners with CARITAS Hospital for drone-based medical deliveries in Kottayam
New Delhi-based startup Skye Air Mobility, a leading drone technology-based logistics firm, has announced a collaboration with CARiTAS Hospital & Institute of Health Sciences, Kottayam, Kerala, to revolutionise medical deliveries through drone technology.
Pristyn Care partners with CureMyKnee to establish CoE for joint replacement surgeries
Gurugram-based startup Pristyn Care, a leading healthcare provider specialising in advanced secondary care surgeries, is establishing a Centre for Excellence (CoE) in Joint Replacement Surgeries with Cure My Knee.
Vipragen, Zumutor form strategic alliance in biologics CRO sector
Bengaluru-based companies Vipragen Biosciences and Zumutor Biologics have announced a strategic partnership to set up an endto-end Biologics Contract Research Organisation (CRO) platform to support discovery, clone to preclinical development of biologics/biosimilars.
Cambrian Bioworks raises $1.45 M to transform molecular diagnostics in India
Bengaluru-based biotechnology startup Cambrian Bioworks has secured $1.45 million in seed funding.
Health Minister introduces National Medical Register Portal of National Medical Commission
Union Minister for Health & Family Welfare, Jagat Prakash Nadda recently inaugurated the National Medical Register (NMR) Portal of the National Medical Commission (NMC) for registration of all the MBBS doctors who are eligible for registration in India, in presence of Union Minister of State (MoS) for Health & Family Welfare, Anupriya Patel and virtual presence of Union MoS for Health & Family Welfare, Prataprao Jadhav.